237 related articles for article (PubMed ID: 33906691)
21. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Lim SS; Jung SH; Ji J; Shin KH; Keum SR
J Pharm Pharmacol; 2001 May; 53(5):653-68. PubMed ID: 11370705
[TBL] [Abstract][Full Text] [Related]
22. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O
Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445
[TBL] [Abstract][Full Text] [Related]
23. Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation.
Papastavrou N; Chatzopoulou M; Ballekova J; Cappiello M; Moschini R; Balestri F; Patsilinakos A; Ragno R; Stefek M; Nicolaou I
Eur J Med Chem; 2017 Apr; 130():328-335. PubMed ID: 28259841
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Iqbal Z; Morahan G; Arooj M; Sobolev AN; Hameed S
Eur J Med Chem; 2019 Apr; 168():154-175. PubMed ID: 30818176
[TBL] [Abstract][Full Text] [Related]
25. Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase.
Yapar G; Esra Duran H; Lolak N; Akocak S; Türkeş C; Durgun M; Işık M; Beydemir Ş
Bioorg Chem; 2021 Dec; 117():105473. PubMed ID: 34768205
[TBL] [Abstract][Full Text] [Related]
26. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
[TBL] [Abstract][Full Text] [Related]
27. Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications.
Vyas B; Choudhary S; Singh PK; Kumar M; Verma H; Singh M; Malik AK; Silakari O
Bioorg Chem; 2020 Mar; 96():103570. PubMed ID: 31978681
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
29. (2,6-Dimethylphenylsulphonyl)nitromethane: a new structural type of aldose reductase inhibitor which follows biphasic kinetics and uses an allosteric binding site.
Ward WH; Cook PN; Mirrlees DJ; Brittain DR; Preston J; Carey F; Tuffin DP; Howe R
Biochem Pharmacol; 1991 Nov; 42(11):2115-23. PubMed ID: 1958230
[TBL] [Abstract][Full Text] [Related]
30. Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study.
Imran A; Shehzad MT; Shah SJA; Al Adhami T; Laws M; Rahman KM; Alharthy RD; Khan IA; Shafiq Z; Iqbal J
Sci Rep; 2022 Apr; 12(1):5734. PubMed ID: 35388067
[TBL] [Abstract][Full Text] [Related]
31. Development, Molecular Docking, and
Imran A; Shehzad MT; Shah SJA; Laws M; Al-Adhami T; Rahman KM; Khan IA; Shafiq Z; Iqbal J
ACS Omega; 2022 Aug; 7(30):26425-26436. PubMed ID: 35936488
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics.
Kumar Pasala V; Gudipudi G; Sankeshi V; Basude M; Gundla R; Singh Jadav S; Srinivas B; Yadaiah Goud E; Nareshkumar D
Bioorg Chem; 2021 Sep; 114():104970. PubMed ID: 34120026
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 2'-oxo-2,3-dihydro-3'H- spiro[chromene-4,5'-[1,3]oxazolidin]-3'yl]acetic acid derivatives as aldose reductase inhibitors.
Rapposelli S; Da Settimo F; Digiacomo M; La Motta C; Lapucci A; Sartini S; Vanni M
Arch Pharm (Weinheim); 2011 Jun; 344(6):372-85. PubMed ID: 21319207
[TBL] [Abstract][Full Text] [Related]
34. Molecular modelling and synthesis of spiroimidazolidine-2,4-diones with dual activities as hypoglycemic agents and selective inhibitors of aldose reductase.
Salem MG; Abdel Aziz YM; Elewa M; Elshihawy HA; Said MM
Bioorg Chem; 2018 Sep; 79():131-144. PubMed ID: 29751319
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.
Iqbal Z; Hameed S; Ali S; Tehseen Y; Shahid M; Iqbal J
Eur J Med Chem; 2015 Jun; 98():127-38. PubMed ID: 26005026
[TBL] [Abstract][Full Text] [Related]
36. Novel rhodanine based inhibitors of aldose reductase of non-acidic nature with p-hydroxybenzylidene functional group.
Kratky M; Sramel P; Bodo P; Prnova MS; Kovacikova L; Majekova M; Vinsova J; Stefek M
Eur J Med Chem; 2023 Jan; 246():114922. PubMed ID: 36455357
[TBL] [Abstract][Full Text] [Related]
37. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.
Tokalı FS; Demir Y; Türkeş C; Dinçer B; Beydemir Ş
Drug Dev Res; 2023 Apr; 84(2):275-295. PubMed ID: 36598092
[TBL] [Abstract][Full Text] [Related]
38. 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
Kato A; Kobayashi K; Narukawa K; Minoshima Y; Adachi I; Hirono S; Nash RJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5630-3. PubMed ID: 20805028
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors.
Salem MG; Aziz YMA; Elewa M; Elshihawy HA; Said MM
Bioorg Med Chem; 2019 Aug; 27(15):3383-3389. PubMed ID: 31221611
[TBL] [Abstract][Full Text] [Related]
40. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
